under-perform price
even feel macro pain
mix quarter food continu struggl
industri slow slightli notabl pi partial off-set solid
lab perform howev mixtur enough caus
step organ revenu growth
year guid also disappoint first cut recal
year put squar in-lin peer organ
growth level year despit valuat forward
price-to-earnings forward ebitda premium valuat
vs tool group undoubtedli warrant given superior
execut mani year view risk/reward
unfavor given extend valuat premium current
state china like busi cycl
mention comp look mighti tough given
element reiter under-perform rate
tweak price target impli perp growth
low doubl digit growth medium term
tariff fx reduc ep full year
organ growth full year
weaker result food retail
expect food dd
pid slightli
better growth america off-set
expect growth l-msd
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
industri growth region
expect solid growth
tough comp
challeng market demand custom time
manag busi profit sale growth
lab core industri well vs tough comp
pid retail
pid core industri growth good
expect l-msd growth
ex-food expect america grow msd full year
growth china
lab dd
outlook remain posit moder growth tough comp
industri hsd
china total compani sale
lab littl less half total china sale
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
laboratori corp america
articl articl
time dissemin august
analyst luke sergott jon bristow ross muken primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer
part research analyst compens directli relat specif recommend view research report
